Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder

• Päätekijät: Joanna Moncrieff (Tekijä), Swapnil Gupta (Tekijä), Mark Abie Horowitz (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: SAGE Publishing, 2020-07-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Most guidelines recommend long-term, indefinite neuroleptic (or antipsychotic) treatment for people with schizophrenia, recurrent psychosis or bipolar disorder, on the basis that these medications reduce the chance of relapse. However, neuroleptics have significant adverse effects, including sexual...